Background: Diabetic retinopathy (DR) is a major cause of blindness globally. Sodium Glucose Cotransporter-2 (SGLT2) inhibitors have been demonstrated to exert cardiorenal protection in patients with diabetes. However. their potential beneficial effect on DR is less well studied. https://www.roneverhart.com/UICIDEBOY-x-REVOLVER-BUNDLE-2023-FALL-ISSUE-W-LONG-TERM-EFFECTS-OF-SUFFERING-LP-SING-ME-A-LULLABY-MY-SWEET-TEMPTATION/